RNAGADE
DEAD

Serial Number

90545048

Owner

Renagade Therapeutics LLC

Attorney

Jonathan M. Gelchinsky

Filing Date

Feb 24, 2021

Add to watchlist:

No watchlists yet
View on USPTO

RNAGADE Trademark

Serial Number: 90545048

RNAGADE is a trademark filed by Renagade Therapeutics LLC on February 24, 2021. The trademark is classified under Class 1 (Chemicals). The application is currently no longer active.

Owner Contact Info

Renagade Therapeutics LLC (6 trademarks)

500 Forge Rd.
Watertown, MA 02472

Entity Type: 16

Trademark Details

Filing Date

February 24, 2021

Registration Date

Not Registered

Published for Opposition

March 1, 2022

Goods & Services

Biochemical catalysts; Biochemical preparations for scientific purposes; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Diagnostic preparations for clinical or medical laboratory use; Diagnostic preparations for scientific or research use; Diagnostic preparations used in science; Nucleic acid for laboratory use; Protein in raw material form for scientific and medical research; Reagents for research purposes; Reagents for scientific and research use; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, infectious disorders and reproductive disorders; Antioxidants for use in the manufacture of pharmaceuticals; Biochemicals for in vitro and in vivo scientific use; Biochemicals, namely, polypeptides for in vitro research use; Biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research purposes; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; Biometallic compounds for use in the manufacture of pharmaceutical preparations; Catalysts for chemical and biochemical processes; Cells for scientific, laboratory or medical research; Chemical additives for use in the manufacture of pharmaceuticals; Chemicals for use in the biochemical and chemical industry; Chemicals for use in the purification of proteins for in vitro use; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Diagnostic reagents for scientific or research use; Enzymes for use in protein hydrolysis; Immunohistochemistry detection kits consisting of mouse secondary reagents, DAB chromogens, DAB buffers, peroxidase blocking reagent, and hematoxylin, for anatomic pathology purposes in the medical diagnostics industry; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; Plant extracts for use in the manufacture of pharmaceuticals; Protein arrays and nucleotide arrays for scientific and medical research; Reagents for scientific or medical research use

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 15, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 15, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 24, 2024 EXRA
SOU EXTENSION 5 GRANTED
Oct 24, 2024 EX5G
SOU EXTENSION 5 FILED
Oct 24, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Oct 24, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 4, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 4, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 4, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 4, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 4, 2024 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 5, 2024 EXRA
SOU EXTENSION 4 GRANTED
Mar 4, 2024 EX4G
SOU EXTENSION 4 FILED
Mar 4, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Mar 4, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 21, 2023 EXRA
SOU EXTENSION 3 GRANTED
Oct 19, 2023 EX3G
SOU EXTENSION 3 FILED
Oct 19, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 19, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 11, 2023 EXRA
SOU EXTENSION 2 GRANTED
Mar 9, 2023 EX2G
SOU EXTENSION 2 FILED
Mar 9, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 9, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 21, 2022 EXRA
SOU EXTENSION 1 GRANTED
Oct 19, 2022 EX1G
SOU EXTENSION 1 FILED
Oct 19, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 19, 2022 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 13, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 13, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 13, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 13, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 13, 2022 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 26, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 1, 2022 NPUB
PUBLISHED FOR OPPOSITION
Mar 1, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 9, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 26, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 26, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 26, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 26, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 26, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 27, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 26, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 26, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 15, 2021 GNRN
NON-FINAL ACTION E-MAILED
Sep 15, 2021 GNRT
NON-FINAL ACTION WRITTEN
Sep 15, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 15, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 26, 2021 NWOS
NEW APPLICATION ENTERED
Feb 27, 2021 NWAP